This announcement is a separate document:
English
Back
- Markets
- Features
- News
- Community
- Learn
- Help Center
- About
- Offers & Rewards
- Welcome RewardsOpen an account and get up to HKD1800!
- Enjoy limited-time 5%+5% returns on Cash PlusInvest any amount and enjoy a 5% average return on Cash Plus + 5% welcome reward
- Join Futubull Membership ProgramUnlock 11 Premier Benefits
- Referral PromotionBring a friend and collect up to HK$600 in rewards
- Learn PremiumAnalyst 1V1 online teaching
- Stock TransferSwitch to Futu and get up to HK$7,000 in rewards
- English
- 繁體中文
- 简体中文
- Dark
- Light
易瑞生物：第三届董事会第九次会议决议公告
Yi Rui Biotech: Announcement of Resolutions of the 9th Meeting of the 3rd Board of Directors
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
15:32
Genesis: The company has yet to directly supply parts related to robots and humanoid robots to related manufacturers
Guangdong Create Century Intelligent Equipment Group Corporation-1.39%
15:31
The head of the relevant departments of the Financial Regulatory Bureau: The "Decision" specifies that "related transactions where the single transaction amount for individuals is below 0.5 million yuan or the single transaction amount for legal persons is below 5 million yuan, and the cumulative total after the transaction has not reached the standard for significant related transactions," can be managed uniformly by the Board of Directors for such transactions, exempting them from individual review.
15:28
The newly launched star drug "Tirzepatide" has officially hit the market in China, selling out in 3 seconds on the first night.
MEITUAN-W-0.32%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.